Duane Morris LLP said Shkreli’s former company Phoenixus AG agreed to cover his legal fees but has refused to pay the $2.04 million owed through March 31, after exhausting the limits of an insurance policy covering the fees in October.
In a filing in Manhattan federal court, Duane Morris also said Shkreli “has no assets” to pay its fees, and would not be harmed if it withdrew because the antitrust trial is over. The law firm said Shkreli did not oppose its withdrawal.Shkreli, 39, became known as “pharma bro” after raising the price of the anti-parisitic drug Daraprim overnight to $750 per tablet from $17.50 in 2015, and appearing unrepentant when criticized.
In January, U.S. District Judge Denise Cote in Manhattan banned Shkreli from the drug industry for life and ordered him to pay $64.6 million, finding he illegally sought to keep generic Daraprim rivals off the market.Shkreli is serving a seven-year prison sentence after being convicted in 2017 of defrauding investors in two hedge funds he ran and scheming to defraud investors in another company.In February, the Brooklyn judge who oversaw the criminal case and a related U.S.
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter.
god damn cheap skate douche